Literature DB >> 28314590

Inflammasome Activation Triggers Caspase-1-Mediated Cleavage of cGAS to Regulate Responses to DNA Virus Infection.

Yutao Wang1, Xiaohan Ning1, Pengfei Gao1, Shuxian Wu2, Mengyin Sha1, Mengze Lv1, Xiang Zhou1, Juyi Gao1, Run Fang1, Guangxun Meng2, Xiaodong Su3, Zhengfan Jiang4.   

Abstract

Viral infection triggers host innate immune responses that result in the production of various cytokines including type I interferons (IFN), activation of inflammasomes, and programmed cell death of the infected cells. Tight control of inflammatory cytokine production is crucial for the triggering of an effective immune response that can resolve the infection without causing host pathology. In examining the inflammatory response of Asc-/- and Casp1-/- macrophages, we found that deficiency in these molecules resulted in increased IFN production upon DNA virus infection, but not RNA virus challenge. Investigation of the underlying mechanism revealed that upon canonical and non-canonical inflammasome activation, caspase-1 interacted with cyclic GMP-AMP (cGAMP) synthase (cGAS), cleaving it and dampening cGAS-STING-mediated IFN production. Deficiency in inflammasome signaling enhanced host resistance to DNA virus in vitro and in vivo, and this regulatory role extended to other inflammatory caspases. Thus, inflammasome activation dampens cGAS-dependent signaling, suggesting cross-regulation between intracellular DNA-sensing pathways.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Innate immunity; STING; cGAS; caspase-1; inflammasome; type I-interferons; viral infection

Mesh:

Substances:

Year:  2017        PMID: 28314590     DOI: 10.1016/j.immuni.2017.02.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  77 in total

Review 1.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

Review 2.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

Review 3.  Caspases control antiviral innate immunity.

Authors:  Huihui Chen; Xiaohan Ning; Zhengfan Jiang
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

4.  Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.

Authors:  Krystal K Lum; Bokai Song; Joel D Federspiel; Benjamin A Diner; Timothy Howard; Ileana M Cristea
Journal:  Cell Syst       Date:  2018-11-21       Impact factor: 10.304

5.  A proximity-dependent biotinylation (BioID) approach flags the p62/sequestosome-1 protein as a caspase-1 substrate.

Authors:  Yvan Jamilloux; Brice Lagrange; Antonia Di Micco; Emilie Bourdonnay; Angélina Provost; Rémy Tallant; Thomas Henry; Fabio Martinon
Journal:  J Biol Chem       Date:  2018-06-21       Impact factor: 5.157

Review 6.  Emerging Proviral Roles of Caspases during Lytic Replication of Gammaherpesviruses.

Authors:  Tate Tabtieng; Marta M Gaglia
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

7.  Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1-caspase-1 axis.

Authors:  Yanyan Zheng; Qingxiang Liu; Yaoxing Wu; Ling Ma; Zhenzhen Zhang; Tao Liu; Shouheng Jin; Yuanchu She; Yi-Ping Li; Jun Cui
Journal:  EMBO J       Date:  2018-07-31       Impact factor: 11.598

8.  Differential signaling pathways are initiated in macrophages during infection depending on the intracellular fate of Chlamydia spp.

Authors:  Uma M Nagarajan; Manoj Tripathy; Avinash Kollipara; John Allen; Anna Goodwin; Judy Whittimore; Priscilla B Wyrick; Roger G Rank
Journal:  Immunol Cell Biol       Date:  2018-01-06       Impact factor: 5.126

Review 9.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

Review 10.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.